A5109895429- Heart Failure Treatment and Management
- Cardiac Arrhythmias and Treatments
- Blood Pressure and Hypertension Studies
- Cardiac pacing and defibrillation studies
- Atrial Fibrillation Management and Outcomes
- Cardiac, Anesthesia and Surgical Outcomes
- Cardiac Structural Anomalies and Repair
- Heart Rate Variability and Autonomic Control
- Nursing care and research
- Educational Outcomes and Influences
- Medication Adherence and Compliance
- Public Health and Social Inequalities
- Lipoproteins and Cardiovascular Health
- Cardiac Health and Mental Health
- Health Systems, Economic Evaluations, Quality of Life
- Cardiomyopathy and Myosin Studies
- Machine Learning in Healthcare
- Cardiovascular and exercise physiology
- Cardiovascular Function and Risk Factors
- Chronic Disease Management Strategies
- Electronic Health Records Systems
- Clinical Reasoning and Diagnostic Skills
- Health and Medical Education
- Hormonal Regulation and Hypertension
Universidad de la República de Uruguay
2009-2020
Hospital de Clínicas
2016-2017
Introducción: La fibrilación auricular (FA) es el trastorno de ritmo cardíaco mayor frecuencia en pacientes con insuficiencia cardíaca (IC) independiente la fracción eyección, conllevando a riesgo complicaciones tromboembólicas. En tratamiento FA, anticoagulación uno los pilares fundamentales. Previo este, se recomienda valorar embólico mediante score CHA2DS2 VASc y sangrado HAS-BLED. Existen dos grupos farmacológicos anticoagulantes orales (ACO), antagonistas vitamina K (AVK), directos...
Chronic heart failure is a growing public health issue that reaching epidemic proportions. In the last few years, multidisciplinary management programs have been developed to improve its management. Yet, some patients take advantage of these programs, whereas others do not.Several demographic, medical, and social variables were evaluated as contributors dropout after enrollment into program using nested case-control design. A total 14 42 controls interviewed standardized questionnaire....
Introducción: La warfarina es uno de los medicamentos más prescritos en el tratamiento y prevención enfermedades tromboembólicas. El beneficio la eventos trombóticos reducción mortalidad está ampliamente documentado. Sin embargo, aspectos relacionados con seguridad han limitado su uso. acompañamiento pacientes, especial atención información educación sobre sus patologías, hábitos saludables, cumplimiento tratamientos comprensión riesgos, fundamental para conseguir buenos resultados,...
Introduction: mineralocorticoid receptor antagonists have been shown to be beneficial in patients with symptomatic heart failure and reduced ejection fraction. However, little evidence is available regarding its hemodynamic effects and, at the same time, there are no loco-regional reports on use real clinical practice. Our preliminary experience analyzed medium term effectiveness safety profile of eplerenone ischemic cardiomyopathy ejection Material methods: a prospective open study was...